Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sequential tranexamic acid for perioperative blood loss in fracture surgery
ChiCTR2100048217Phase 4Not yet recruiting
- Sponsor
- First Affiliated Hospital of Chongqing Medical University
- Start
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of tranexamic acid in Femoral diaphyseal fracture, intertrochanteric fracture, subtrochanteric fracture and 7 more (2 arms), sponsored by First Affiliated Hospital of Chongqing Medical University. Primary endpoints: Total blood loss, Preoperative blood loss and 1 more. Planned start Jul 2021; status: not yet recruiting.
02
Drugs
tranexamic acid
03
Conditions
Femoral diaphyseal fractureintertrochanteric fracturesubtrochanteric fracturepelvic fractureacetabular fracture
Beyond the preview
Go deeper on ChiCTR2100048217.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100048217.